Medical Doctor Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Ganesh Balu

Interventional Pain Medicine Dover, DE Medical Doctor

NPI 1073594693 CMS profile 3097

240 Beiser Blvd, Suite 201, Dover, DE 19904

Open in the dashboard

General payments

$5,693

174 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Ganesh Balu of Dover, DE is reported in the CMS Open Payments database as having received $5,693 across 174 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 59th percentile of Interventional Pain Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $157 7
2023 General $764 18
2022 General $510 15
2021 General $414 16
2020 General $2,070 32
2019 General $1,779 86

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ganesh Balu
  • Interventional Pain Medicine median
  • Middle half of Interventional Pain Medicine
  • National median

In program year 2025, general payments to Ganesh Balu were reported at $0. Among 1,891 Interventional Pain Medicine profiles paid that year, the median was $657 and the middle half received between $184 and $1,753.

Show as a table
Year Ganesh Balu Interventional Pain Medicine median Middle half National median
2019 $1,779 $684 $216–$2,079 $163
2020 $2,070 $382 $122–$1,109 $114
2021 $414 $552 $167–$1,554 $132
2022 $510 $605 $187–$1,924 $149
2023 $764 $671 $195–$1,915 $160
2024 $157 $684 $206–$1,837 $164
2025 $0 $657 $184–$1,753 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Boston Scientific Corporation $1,890 17 payments
  2. Medtronic USA, Inc. $1,084 81 payments
  3. Medtronic, Inc. $858 29 payments
  4. Abbott Laboratories $374 14 payments
  5. SPR Therapeutics, Inc $237 5 payments
  6. Stimwave Technologies Incorporated $180 1 payment
  7. Painteq LLC $177 3 payments
  8. Biodelivery Sciences International, Inc. $158 2 payments
  9. Curonix LLC $137 1 payment
  10. Nevro Corp. $118 5 payments
  11. Other $478 16 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Food and Beverage $4,239 168 payments
  2. Travel and Lodging $1,454 6 payments
Products named General payments · program years 2019–2024
  1. SUPERION $1,714 9 payments
  2. VECTRIS $425 42 payments
  3. INTELLIS $343 21 payments
  4. INTELLIS ADAPTIVESTIM $331 8 payments
  5. SPRINT PNS System $237 5 payments
  6. PAINTEQ $177 3 payments
  7. BELBUCA $158 2 payments
  8. Proclaim Family of SCS IPGs $142 4 payments
  9. PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A $137 1 payment
  10. VANTA ADAPTIVESTIM $134 8 payments
  11. Other $1,506 64 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

174 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Pain Medicine in Delaware

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record